Lypo-hypertrofia Characterization in Diabetes

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Type 1 Diabetes Mellitus
Interventions
OTHER

Ultrasound

Ultrasound measurements

OTHER

Tapping and body inspection to define the area of insulin injection

Obese patients with a thickening fat subcutaneous tissue that could have interfered with the interpreting and analyzing of the data are left out of this first study. In the control group we manage to define the lypo-hypertrophic area by tapping and body inspection

Trial Locations (1)

20162

Nigurada Hospital, Milan

All Listed Sponsors
lead

Niguarda Hospital

OTHER

NCT02278926 - Lypo-hypertrofia Characterization in Diabetes | Biotech Hunter | Biotech Hunter